ArticleInternational journal of nephrology2014
Annual decline in pentraxin 3 is a risk of vascular access troubles in hemodialysis patients.
Kei Nagai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it